Knobloch K, Vogt P M
Plastische, Hand- und Wiederherstellungschirurgie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover.
Chirurg. 2010 May;81(5):441-6. doi: 10.1007/s00104-010-1917-3.
Mathes and Nahai introduced the conventional reconstructive ladder in 1982 to address tissue defects starting with primary and secondary closure of wounds followed by autologous skin grafting. Regional and local pedicled flaps, tissue expansion and free tissue transfer were further steps. Despite enormous achievements and refinements in these techniques, clinical situations and problems occur beyond the scope of these conventional reconstructive measures. Composite tissue allotransplantation (CTA) of partial faces or of unilateral or bilateral forearms and upper arms, are a novel part of transplantation medicine. The initially reported clinical results are encouraging, especially in light of the initial clinical reports of organ transplantation. However, short and long term problems such as potential tumor induction by immunosuppression and chronic rejection must be taken into consideration. Given the fact that patients receiving CTA have already undergone various reconstructive procedures before, patients often gain tremendous improvement in the quality of life. Robots such as the Da Vinci system for surgeons and the Penelope assistant robot have found their way into the surgical routine. While even microsurgical anastomosis has been accomplished using the Da Vinci system, the total amount of time and resources spent is beyond being practical at present. Regeneration and tissue engineering are of distinct interest in reconstructive surgery. Adipose-derived stem cell transfer is able not only to improve contour defects by volume effects, but also to improve the quality of the overlying skin. Therefore we would propose that these novel techniques, CTA, robotics, regeneration and tissue engineering should be considered as potential future integral cogs in the reconstructive mechanism for the 21st century with the patient being at the centre of the reconstructive efforts.
1982年,马西斯和纳海引入了传统的重建阶梯,以解决组织缺损问题,首先是伤口的一期和二期缝合,然后是自体皮肤移植。区域和局部带蒂皮瓣、组织扩张和游离组织移植是进一步的步骤。尽管这些技术取得了巨大成就并不断完善,但临床情况和问题超出了这些传统重建措施的范围。部分面部或单侧或双侧前臂及上臂的复合组织异体移植(CTA)是移植医学的一个新领域。最初报道的临床结果令人鼓舞,特别是鉴于器官移植的最初临床报告。然而,必须考虑到短期和长期问题,如免疫抑制可能导致肿瘤诱导和慢性排斥反应。鉴于接受CTA的患者此前已经接受了各种重建手术,患者的生活质量往往有了极大改善。达芬奇系统等外科手术机器人以及佩内洛普辅助机器人已经进入手术常规。虽然使用达芬奇系统甚至已经完成了显微外科吻合,但目前所花费的总时间和资源并不实用。再生和组织工程在重建外科中具有独特的意义。脂肪来源干细胞移植不仅能够通过体积效应改善轮廓缺损,还能改善覆盖皮肤的质量。因此,我们建议,这些新技术,即CTA、机器人技术、再生和组织工程,应被视为21世纪重建机制中未来潜在的重要组成部分,患者应是重建努力的核心。